Brigitte Bernard‐Chabert

3.0k total citations
25 papers, 821 citations indexed

About

Brigitte Bernard‐Chabert is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Brigitte Bernard‐Chabert has authored 25 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 19 papers in Hepatology and 8 papers in Surgery. Recurrent topics in Brigitte Bernard‐Chabert's work include Liver Disease Diagnosis and Treatment (17 papers), Liver Disease and Transplantation (8 papers) and Hepatitis C virus research (7 papers). Brigitte Bernard‐Chabert is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Liver Disease and Transplantation (8 papers) and Hepatitis C virus research (7 papers). Brigitte Bernard‐Chabert collaborates with scholars based in France, United States and Switzerland. Brigitte Bernard‐Chabert's co-authors include Dominique Thabut, Éric Nguyen-Khac, Marika Rudler, Thierry Thévenot, Marie‐Astrid Piquet, S. Benferhat, Denis Chatelain, Odile Goria, B. Tramier and H Tossou and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of the American College of Cardiology.

In The Last Decade

Brigitte Bernard‐Chabert

23 papers receiving 795 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brigitte Bernard‐Chabert France 15 551 352 279 152 139 25 821
Ajith Kumar Sankarankutty Brazil 14 130 0.2× 149 0.4× 48 0.2× 25 0.2× 299 2.2× 69 638
Teresa M. Curto United States 16 1.1k 2.0× 981 2.8× 50 0.2× 57 0.4× 156 1.1× 25 1.5k
Rajiv Baijal India 14 680 1.2× 300 0.9× 137 0.5× 312 2.1× 277 2.0× 29 1.0k
Pavel Taimr Netherlands 13 449 0.8× 356 1.0× 60 0.2× 110 0.7× 161 1.2× 26 724
Neeral L. Shah United States 20 843 1.5× 949 2.7× 95 0.3× 164 1.1× 454 3.3× 55 1.5k
Diego García‐Compeán Mexico 18 657 1.2× 481 1.4× 74 0.3× 246 1.6× 572 4.1× 65 1.3k
Ying Peng China 16 727 1.3× 750 2.1× 44 0.2× 23 0.2× 331 2.4× 34 1.0k
André Weigert Portugal 12 228 0.4× 289 0.8× 19 0.1× 39 0.3× 195 1.4× 57 685
Irina Gîrleanu Romania 13 457 0.8× 247 0.7× 33 0.1× 82 0.5× 177 1.3× 75 743
Lukas Hartl Austria 18 749 1.4× 735 2.1× 69 0.2× 70 0.5× 250 1.8× 75 951

Countries citing papers authored by Brigitte Bernard‐Chabert

Since Specialization
Citations

This map shows the geographic impact of Brigitte Bernard‐Chabert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitte Bernard‐Chabert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitte Bernard‐Chabert more than expected).

Fields of papers citing papers by Brigitte Bernard‐Chabert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigitte Bernard‐Chabert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitte Bernard‐Chabert. The network helps show where Brigitte Bernard‐Chabert may publish in the future.

Co-authorship network of co-authors of Brigitte Bernard‐Chabert

This figure shows the co-authorship network connecting the top 25 collaborators of Brigitte Bernard‐Chabert. A scholar is included among the top collaborators of Brigitte Bernard‐Chabert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigitte Bernard‐Chabert. Brigitte Bernard‐Chabert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bernard‐Chabert, Brigitte, Jean–Pierre Bronowicki, François Habersetzer, et al.. (2024). Association between the dietary inflammatory index and the risk of hepatocellular carcinoma in a cirrhotic population. Clinical Nutrition. 44. 65–75. 1 indexed citations
2.
Cluzel, Philippe, Philippe Sultanik, Brigitte Bernard‐Chabert, et al.. (2021). Prognosis of patients undergoing salvage TIPS is still poor in the preemptive TIPS era. Clinics and Research in Hepatology and Gastroenterology. 45(6). 101593–101593. 16 indexed citations
3.
Barbe, Coralie, Alexandra Heurgué–Berlot, Thierry Thévenot, et al.. (2020). Sustained Remission After Treatment Withdrawal in Autoimmune Hepatitis: A Multicenter Retrospective Study. Digestive Diseases and Sciences. 66(6). 2107–2117.
4.
Alric, Laurent, Isabelle Ollivier‐Hourmand, Emilie Bérard, et al.. (2018). Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective. Kidney International. 94(1). 206–213. 18 indexed citations
5.
Rudler, Marika, Christophe Bureau, Nicolas Carbonell, et al.. (2017). Recalibrated MELD and hepatic encephalopathy are prognostic factors in cirrhotic patients with acute variceal bleeding. Liver International. 38(3). 469–476. 21 indexed citations
6.
Thabut, Dominique, Marika Rudler, Nina Dib, et al.. (2014). Multicenter prospective validation of the Baveno IV and Baveno II/III criteria in cirrhosis patients with variceal bleeding. Hepatology. 61(3). 1024–1032. 14 indexed citations
7.
Zhang, Xiaoqing, Gérard Thiéfin, Cyril Gobinet, et al.. (2013). Profiling serologic biomarkers in cirrhotic patients via high-throughput Fourier transform infrared spectroscopy: toward a new diagnostic tool of hepatocellular carcinoma. Translational research. 162(5). 279–286. 32 indexed citations
8.
Petit, Jean Michel, Samia Hamza, Fabien Rollot, et al.. (2013). Impact of liver disease severity and etiology on the occurrence of diabetes mellitus in patients with liver cirrhosis. Acta Diabetologica. 51(3). 455–60. 21 indexed citations
9.
Thiéfin, Gérard, Cyril Gobinet, Valérie Untereiner, et al.. (2013). Diagnosis of hepatocellular carcinoma in cirrhotic patients: a proof-of-concept study using serum micro-Raman spectroscopy. The Analyst. 138(14). 4006–4006. 50 indexed citations
10.
Nguyen-Khac, Éric, Thierry Thévenot, Marie‐Astrid Piquet, et al.. (2011). Glucocorticoids plusN-Acetylcysteine in Severe Alcoholic Hepatitis. New England Journal of Medicine. 365(19). 1781–1789. 285 indexed citations
11.
Nguyen-Khac, Éric, Thierry Thévenot, Marie‐Astrid Piquet, et al.. (2010). 83 TREATMENT OF SEVERE ACUTE ALCOHOLIC HEPATITIS (AAH) WITH CORTICOIDS PLUS N-ACETYL CYSTEINE (C+NAC) VERSUS CORTICOIDS ALONE (C): A MULTICENTRE, RANDOMIZED, CONTROLLED TRIAL. Journal of Hepatology. 52. S38–S38. 4 indexed citations
12.
Heurgué, Alexandra, et al.. (2009). Overlap syndrome triggered by acute viral hepatitis A. European Journal of Gastroenterology & Hepatology. 21(6). 708–709. 2 indexed citations
13.
Oberti, Frédéric, Pierre Bernard, Éric Bartoli, et al.. (2007). Management practices for gastrointestinal hemorrhage related to portal hypertention in cirrhotic patients: evaluation of the impact of the Paris consensus workshop. Gastroentérologie Clinique et Biologique. 31(11). 970–974. 6 indexed citations
14.
Heurgué, Alexandra, Fabien Vitry, Marie-Danièle Diébold, et al.. (2007). Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease. Gastroentérologie Clinique et Biologique. 31(1). 17–25. 55 indexed citations
15.
Massard, Julien, Brigitte Bernard‐Chabert, Vincent Di Martino, et al.. (2007). Continuous infusion of high‐dose omeprazole is more effective than standard‐dose omeprazole in patients with high‐risk peptic ulcer bleeding: a retrospective study. Alimentary Pharmacology & Therapeutics. 25(8). 949–954. 14 indexed citations
16.
Orgiazzi, Jacques, et al.. (2006). Interferon-α-induced hyperthyroidism: a three-stage evolution from silent thyroiditis towards Graves’ disease. European Journal of Endocrinology. 154(3). 367–372. 25 indexed citations
17.
Leymarie, F., Brigitte Delemer, Stéphane Lévy, et al.. (2005). Risk factors and long-term course of thyroid dysfunction during antiviral treatments in 221 patients with chronic hepatitis C. Gastroentérologie Clinique et Biologique. 29(4). 339–345. 34 indexed citations
18.
Heurgué, Alexandra, Brigitte Bernard‐Chabert, Thierry Higuero, et al.. (2004). Atteinte hépatique aiguë cholestatique induite par le glimépiride. Annales d Endocrinologie. 65(2). 174–175. 4 indexed citations
19.
Thabut, Dominique, Vincent Thibault, Brigitte Bernard‐Chabert, et al.. (2004). Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis B. European Journal of Gastroenterology & Hepatology. 16(12). 1367–1373. 19 indexed citations
20.
Thabut, Gabriel, Dominique Thabut, Robert P. Myers, et al.. (2002). Thrombolytic therapy of pulmonary embolism. Journal of the American College of Cardiology. 40(9). 1660–1667. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026